Hutchinson-Gilford Syndrome: History, Causes, Phenotype and Research Advances
June 2023
in “
Zenodo (CERN European Organization for Nuclear Research)
”
Studysummary This review discusses Hutchinson-Gilford Progeria Syndrome, its symptomatology, and the progress in developing treatment strategies, emphasizing that while a cure remains elusive, advances in understanding the disease's molecular mechanisms show promise for future approaches. Our plain-language summary of this paper — not a Tressless recommendation.
Hutchinson-Gilford Progeria Syndrome (HGPS) is an autosomal-dominant genetic disorder caused by a mutation in exon 11 of the LMNA gene, leading to abnormal Lamin A formation. This results in accelerated aging and premature death due to cardiovascular complications. Symptoms include alopecia, lack of subcutaneous fat, growth retardation, skin pigmentation, joint contractures, osteoporosis, and cardiovascular issues, often culminating in myocardial infarction and strokes during childhood. The review highlights the history, symptoms, and treatment advances for HGPS, noting that current management focuses on symptom treatment and complication prevention, with no cure available yet. However, a deeper understanding of the disease's molecular mechanisms is paving the way for improved future treatment strategies.
